Simplex Trading’s 89bio ETNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-108,245
| Closed | -$1.59M | – | 8950 |
|
|
2025
Q3 | $1.59M | Buy |
108,245
+99,052
| +1,077% | +$1.01M | ﹤0.01% | 2557 |
|
|
2025
Q2 | $90K | Buy |
9,193
+5,507
| +149% | +$45.6K | ﹤0.01% | 5342 |
|
|
2025
Q1 | $26K | Buy |
+3,686
| New | +$32.2K | ﹤0.01% | 6358 |
|
|
2024
Q4 | – | Sell |
-7,925
| Closed | -$65.3K | – | 8797 |
|
|
2024
Q3 | $58K | Buy |
7,925
+5,870
| +286% | +$49.4K | ﹤0.01% | 5759 |
|
|
2024
Q2 | $16K | Buy |
+2,055
| New | +$18.4K | ﹤0.01% | 7067 |
|
|
2024
Q1 | – | Sell |
-5,133
| Closed | -$56.8K | – | 9107 |
|
|
2023
Q4 | $57K | Sell |
5,133
-97,542
| -95% | -$897K | ﹤0.01% | 5956 |
|
|
2023
Q3 | $1.58M | Buy |
102,675
+68,817
| +203% | +$1.16M | ﹤0.01% | 2278 |
|
|
2023
Q2 | $641K | Sell |
33,858
-123,842
| -79% | -$2.17M | ﹤0.01% | 3047 |
|
|
2023
Q1 | $2.4M | Buy |
157,700
+88,017
| +126% | +$1.15M | ﹤0.01% | 1791 |
|
|
2022
Q4 | $887K | Buy |
+69,683
| New | +$627K | ﹤0.01% | 2572 |
|
|
2022
Q3 | – | Sell |
-20,057
| Closed | -$88.1K | – | 10152 |
|
|
2022
Q2 | $64K | Buy |
20,057
+19,912
| +13,732% | +$60.1K | ﹤0.01% | 6165 |
|
|
2022
Q1 | $0 | Buy |
+145
| New | +$934 | ﹤0.01% | 10645 |
|
|
2021
Q4 | – | Sell |
-3,481
| Closed | -$55K | – | 10716 |
|
|
2021
Q3 | $64K | Hold |
3,481
| – | – | ﹤0.01% | 7213 |
|
|
2021
Q2 | $65K | Sell |
3,481
-8,138
| -70% | -$182K | ﹤0.01% | 7304 |
|
|
2021
Q1 | $275K | Buy |
+11,619
| New | +$268K | ﹤0.01% | 4252 |
|
Other funds holding ETNB
Simplex Trading's ETNB Position: Q4 2025 in Review
Simplex Trading sold out of 89bio (ETNB) in Q4 2025, closing a stake of 108,245 shares — an estimated $1.59M sold.
Simplex Trading first reported a position in ETNB in Q1 2021 and held it in 15 quarters. The position peaked at $2.4M in Q1 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.
- Simplex Trading reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 108,245 89bio shares in Q4 2025, an estimated $1.59M.
- Simplex Trading first reported a position in 89bio in Q1 2021 and held it in 15 quarters.
- Simplex Trading's 89bio position peaked at $2.4M in Q1 2023.
- 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.